GIP also affects insulin release and, importantly, appears to influence how the body stores and metabolizes fat
GSK-3 inhibitors GSK-3 regulates multiple critical intracellular signalling pathways and it has been implicated in the pathogenesis of numerous diseases, including cancer [305], myocardial diseases [306], and neurodegenerative diseases [307]
However, this same mechanism is responsible for nausea, bloating, vomiting, and early satiety, especially when the body has not yet adapted to the drug
If you experience severe or persistent side effects, contact your GP or NHS 111 for advice
For the digestive system, the practical takeaway is simple
Appetite Signaling and Feeding Behavior Research Another area of investigation involves appetite signaling and feeding behavior pathways